How does stem cell therapy help Alzheimer's disease?

MSCs reduce neuroinflammation, clear amyloid-beta deposits, release neurotrophic factors that support surviving neurons, and promote neurogenesis. These mechanisms can slow cognitive decline and improve daily functioning in Alzheimer's patients.

Can stem cell therapy reverse Alzheimer's symptoms?

While MSC therapy cannot reverse existing brain damage, many patients experience stabilization or improvement in cognitive function, memory, orientation, and daily living activities. Earlier intervention typically yields better outcomes.

What is the difference between Alzheimer's and dementia stem cell therapy?

Alzheimer's is the most common cause of dementia. Our Alzheimer's-specific protocol targets amyloid pathology and tau protein accumulation with optimized MSC doses and delivery routes, including intrathecal administration for direct CNS access.

How many treatments are needed for Alzheimer's?

Most Alzheimer's patients receive an initial treatment course of 1-2 sessions with 50-100 million MSCs via IV and intrathecal delivery. Follow-up treatments at 6-12 month intervals are recommended to maintain and build on improvements.

Alzheimer's Disease Stem Cell Therapy in Istanbul, Turkey

Stem cell therapy for Alzheimer's disease in Istanbul, Turkey. MSC treatments reduce neuroinflammation, promote neurogenesis, protect surviving neurons, and slow cognitive decline. Intrathecal and IV delivery for maximum neuroprotective effect.

About Alzheimers Stem Cell Therapy in Istanbul

Stem cell therapy for Alzheimer's disease at StemCell Longevita in Istanbul, Turkey targets neuroinflammation, amyloid pathology, and synaptic dysfunction to help slow cognitive decline. Our MSC treatments offer a regenerative approach for patients and families facing this challenging neurodegenerative condition, promoting neuroprotection and supporting brain repair mechanisms.

How Stem Cell Therapy Works for This Condition

Alzheimer's disease involves chronic neuroinflammation, amyloid-beta plaque accumulation, tau tangle formation, and progressive synaptic loss. MSCs address multiple pathological pathways simultaneously: they reduce microglial overactivation and neuroinflammation, promote the clearance of amyloid-beta through enhanced microglial phagocytosis, release neurotrophic factors that protect surviving neurons, and improve cerebral blood flow. Research in Alzheimer's Research & Therapy demonstrates cognitive improvements in MSC-treated patients.

Who Is a Candidate?

Best suited for patients with mild cognitive impairment (MCI) or mild-to-moderate Alzheimer's disease, where more neurons remain available for protection. Patients with a family history of Alzheimer's seeking preventive neuroprotection may also benefit. Our neurological team evaluates each patient's cognitive assessments, brain imaging, and biomarkers to determine candidacy.

Treatment Process at StemCell Longevita

Treatment begins with review of cognitive assessments (MMSE, MoCA scores), brain MRI or PET imaging, and medical history. In Istanbul, patients receive comprehensive neurological evaluation before combined IV and intrathecal MSC delivery. The intrathecal route is critical for Alzheimer's as it delivers cells directly to the cerebrospinal fluid, maximizing brain exposure. Treatment takes 3-5 days.

Expected Results & Recovery

Patients may experience stabilization or improvement in memory recall, improved attention and focus, enhanced verbal communication, better spatial awareness, improved ability to perform daily activities (ADL scores), and better mood and sleep. Early-stage patients typically show the strongest response. Benefits develop over 3-6 months.

Why Choose Turkey for Treatment?

Istanbul offers world-class neurological care at 60-80% lower cost than the US or UK. Our team has treated hundreds of patients with neurodegenerative conditions, bringing specific expertise in optimizing MSC protocols for cognitive conditions.

Cost of Treatment

Alzheimer's stem cell therapy from €7,500, including combined IV + intrathecal protocol, cognitive assessment, neurological evaluation, hotel, transfers, and 12-month cognitive follow-up.

Part of Our Neurological Conditions Treatment Cluster

Neurological Conditions — Treatment Cluster

Pillar: stem cell therapy for neurological conditions in Istanbul

Research & guides: stem cell therapy for cerebral palsy research | MSC treatment for autism spectrum disorder | stem cell therapy for stroke recovery in Turkey | MSC treatment for spinal cord injury rehabilitation

Frequently Asked Questions About Alzheimer's Disease Stem Cell Therapy

How does stem cell therapy help Alzheimer's disease?: MSCs reduce neuroinflammation, clear amyloid-beta deposits, release neurotrophic factors that support surviving neurons, and promote neurogenesis. These mechanisms can slow cognitive decline and improve daily functioning in Alzheimer's patients.
Can stem cell therapy reverse Alzheimer's symptoms?: While MSC therapy cannot reverse existing brain damage, many patients experience stabilization or improvement in cognitive function, memory, orientation, and daily living activities. Earlier intervention typically yields better outcomes.
What is the difference between Alzheimer's and dementia stem cell therapy?: Alzheimer's is the most common cause of dementia. Our Alzheimer's-specific protocol targets amyloid pathology and tau protein accumulation with optimized MSC doses and delivery routes, including intrathecal administration for direct CNS access.
How many treatments are needed for Alzheimer's?: Most Alzheimer's patients receive an initial treatment course of 1-2 sessions with 50-100 million MSCs via IV and intrathecal delivery. Follow-up treatments at 6-12 month intervals are recommended to maintain and build on improvements.